Bradycardia clinical trials at UCSD

1 research study open to eligible people

BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
open to eligible people ages 18 years and up
The objective of this Investigational Device Exemption trial is to confirm the safety and performance of the LivIQ leadless pacemaker system, in patients with a Class I or II indication for ventricular pacing (VVI/VDD) according to applicable guidelines. An integrated atrioventricular synchrony sub-study (AVS) is specifically designed to evaluate the AVS performance of the LivIQ system.
La Jolla, California and other locations

Last updated: September 22, 2026

BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System